You are here

Cell Transplantation

Cell Transplantation

eISSN: 15553892 | ISSN: 09636897 | Current volume: 29 | Current issue: 1 Frequency: Continuous
CLL (Cell Transplantation)

Impact Factor: 2.885
Indexed In: CABI: CAB Abstracts, CABI: Global Health, Clarivate Analytics: BIOSIS Previews, Clarivate Analytics: Current Contents - Life Sciences, Clarivate Analytics: Science Citation Index, Clarivate Analytics: Science Citation Index Expanded, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), PubMed: MEDLINE, SCOPUS

Cell Transplantation is a peer-reviewed open access journal which focusses on cell transplantation and its applications to human diseases. Please see the Aims and Scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).

Submission information

Please see the Submission Guidelines tab for more information on how to submit your article to the journal.

Open access article processing charge (APC) information

Publication is subject to payment of an article processing charge (APC). The APC serves to support the journal and ensures that articles are freely accessible online in perpetuity under a Creative Commons licence. The APC for this journal is currently $2300 USD. 

The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.


Please direct any queries to

Cell Transplantation publishes original, peer-reviewed research and review articles on the subject of cell transplantation and its application to human diseases. To ensure high-quality contributions from all areas of transplantation, separate section editors and editorial boards have been established. Articles deal with a wide range of topics including physiological, medical, preclinical, tissue engineering, and device-oriented aspects of transplantation of nervous system, endocrine, growth factor-secreting, bone marrow, epithelial, endothelial, and genetically engineered cells, among others. Basic clinical studies and immunological research papers are also featured. To provide complete coverage of this revolutionary field, Cell Transplantation will report on relevant technological advances and ethical and regulatory considerations of cell transplants. Cell Transplantation has been free to read since 2009.

Paul R. Sanberg University of South Florida Morsani College of Medicine, USA
Shinn-Zong Lin Tzu Chi University, Taiwan
Managing Editors
Donna Morrison University of South Florida Morsani College of Medicine, USA
Ryan Kovacs University of South Florida Morsani College of Medicine, USA
Cardiovascular System, Skin, and Other Tissues
Section Editor: Amit Patel University of Miami School of Medicine, USA
Piero Anversa New York Medical College, USA
Enio Buffolo Federal University of São Paulo, Brazil
Wangde Dai University of Southern California, USA
Henricus D. Duckers Erasmus University Medical Center, The Netherlands
Joshua Hare University of Miami, USA
Nelson A. Hossne, Jr. Federal University of São Paulo, Brazil
Jens Kastrup University of Copenhagen, Denmark
Ren Ke Li University of Toronto, Canada
Virginia M. Miller Mayo Clinic College of Medicine, USA
Marc S. Penn Summa Cardiovascular Institute, USA
Warren Sherman Columbia University, USA
Christof Stamm Deutches Herzzentrum Berlin, Germany
Section Editor: Roberto Gramignoli Karolinska Insitutet, Sweden
Section Editor: Bruno Christ Martin Luther University, Germany
J. Roy Chowdhury Albert Einstein College of Medicine, USA
Anil Dhawan King's College Hospital, UK
Ewa Ellis Karolinska Institute, Sweden
Ira Fox University of Pittsburgh, USA
Mariá José Gómez-Lechón Hospital La Fe, Spain
Toshihiro Mitaka Sapporo Medical University, Japan
Andreas Nüssler University of Tübingen, Germany
Kazuo Ohashi Tokyo Women's Medical University, Japan
Michael Ott Hannover Medical School, Germany
Paolo Parini Karolinska Institute, Sweden
Etienne M. Sokal Université Catholique de Louvain, Belgium
Donna Stolz University of Pittsburgh, USA
Shuji Terai Yamaguchi University, Japan
Islets and Other Endocrines
Section Editor: Rodolfo Alejandro University of Miami School of Medicine, USA
Thierry Berney Geneva University Hospital, Switzerland
Federico Bertuzzi Ospedale Niguarda Cà Granda, Italy
Susan Bonner-Weir Joslin Diabetes Center, USA
Luis Fernandez H4/782 Clinical Science Center, USA
Alberto Hayek The Whittier Institute, USA
Jose Oberholzer University of Illinois at Chicago, USA
Klearchos K. Papas University of Arizona, USA
Lorenzo Piemonti San Raffaele Scientific Institute, Italy
Michael R. Rickels University of Pennsylvania, USA
Peter Senior Alberta Diabetes Institute, Edmonton, Canada
Charmaine J. Simeonovic Australian National University, Australia
Stacey Walters Garvan Institute of Medical Research, Australia
Yong Wang University of Illinois at Chicago, USA
Gordon C. Weir Joslin Diabetes Center, USA
Methods and New Technologies
Section Editor: Dragos Cretoiu Carol Davila University of Medicine and Pharmacy, Romania
Reinhard Bretzel Justus-Liebig University, Germany
Wei-Ming Duan Ohio University, USA
Luca Falqui San Raffaele Scientific Institute, Italy
Craig R. Halberstadt Tengion, Inc., USA
Roger James University of Leicester, UK
Norma Sue Kenyon University of Miami School of Medicine, USA
Jonathan Lakey University of California Irvine, USA
Walter Low University of Minnesota, USA
Hyeyoung Moon Korea Basic Science Institute, Korea
Waldemar L. Olszewski Polish Academy of Sciences, Poland
Gary Peltz Stanford University School of Medicine, USA
Artur Pasternak Jagiellonian University Medical College, Poland
Evan Y. Snyder Burnham Institute for Medical Research, USA
Junjie Xiao Shanghai University, China
Muscle, Bone, and Cartilage
Johnny Huard Steadman Philippon Research Institute, USA
Stanislaw Moskalewski Medical School of Warsaw, Poland
Terence A. Partridge Children's National Medical Center, USA
Myron Spector VA Boston Healthcare System, USA
Jean-Thomas Vilquin INSERM, France
Neuroscience and Tissue Engineering
Section Editor: Mari Dezawa Tohoku University, Japan
Section Editor: Marina Emborg University of Wisconsin, USA
Section Editor: David Eve University of South Florida, USA
Section Editor: Hideki Hida Nagoya City University, Japan
Section Editor: John R. Sladek University of Colorado, USA
Section Editor: Kwok-Fai So University of Hong Kong, Hong Kong
Section Editor: Lyandysha Zholudeva Gladstone Institutes, USA
Elisabet Åkesson Karolinska Institute, Sweden
Ernest Arenas Karolinska Institute, Sweden
Johannes Boltze University of Warwick, UK
Michael Chopp Henry Ford Hospital, USA
Isao Date Okayama University, Japan
Gary Dunbar Central Michigan University, USA
John Elsworth Yale University, USA
Thomas B. Freeman University of South Florida, USA
Monte A. Gates University of Keele, UK
David C. Hess Medical College of Georgia, USA
Stuart I. Hodgetts University of Western Australia, Australia
Hongyun Huang Capital Medical University, China
Kyung-Sun Kang Seoul National University, Korea
Emma Lane Cardiff University, UK
Robert S. Langer Massachusetts Institute of Technology, USA
Agnes Luo Case Western Reserve University, USA
Antonios G. Mikos Rice University, USA
Robert M. Nerem Georgia Institute of Technology, USA
Guido Nikkhah Albert-Ludwigs-University, Germany
Giles Plant Stanford University School of Medicine, USA
Michael Sefton University of Toronto, Canada
Ashok Shetty Texas A&M Health Science Center, USA
Jihwan Song CHA University, Korea
Yun Wang National Institute on Drug Abuse, NIH, USA
John A. Watt University of North Dakota, USA
Hans Widmer Bern University Hospital, Switzerland
Takao Yasuhara Okayama University, Japan
Pain Medicine
Section Editor: Jui-An Lin Taipei Medical University, Taiwan
Ke-Vin Chang National Taiwan University, Taiwan
Chih-Hwa Chen Taipei Medical University, Taiwan
Jen-Yin Chen Chi Mei Medical Center, Taiwan
Jen-Kun Cheng MacKay Memorial Hospital, Taiwan
Jianguo Cheng Cleveland Clinic, USA
Kuang-I Cheng Kaohsiung Medical University, Taiwan
Chun-Jen Huang Taipei Medical University, Taiwan
Alan D. Kaye Louisiana State University School of Medicine, USA
Chih-Peng Lin National Taiwan University, Taiwan
Ricardo Ruiz-López CLINICA VERTEBRA, Spain
Giustino Varrassi Paolo Procacci Foundation, Rome, Italy
Chih-Shung Wong Cathay General Hospital, Taiwan
Jia-Lin Wu Taipei Medical University, Taiwan
Shigeki Yamaguchi Dokkyo Medical University, Tochigi, Japan
Stem Cells, Progenitors, and Bone Marrow
Section Editor: Maria Carolina Oliveira Rodrigues University of São Paulo, Brazil
Section Editor: Lei Xu National Cancer Institute, National Institutes of Health, USA
Section Editor: Li-Ru Zhao SUNY Upstate Medical University, USA
Kerry Atkinson Mater Medical Research Institute, Australia
Hal E. Broxmeyer Indiana University, USA
Francesca Cicchetti CHUL, Canada
Curt I. Civin Johns Hopkins University, USA
Antonio Ibarra Universidad Anáhuac México Norte, Mexico
Kyu-Shik Jeong Kyungpook National University, Korea
Helen Kaipe Karolinska Institutet, Sweden
Giampiero La Rocca University of Palermo, Italy
Oscar K. Lee National Yang-Ming University, Taiwan
Daniela Moraes University of São Paulo, Brazil
Manash Paul University of California-Los Angeles, USA
Ching-Tien Peng China Medical University, Taiwan
Mariusz Ratajczak University of Louisville, USA
Bernat Soria Catedratico Extraordinario de Medicina Regenerativa, Spain
Gerald J. Spangrude University of Utah, USA
John E. Wagner University of Minnesota, USA
Susanne Wolbank Ludwig Boltzmann Institute, Austria
Khang-Hsi Wu China Medical University, Taiwan
Translational Science
Section Editor: Shinn-Zong Lin Hualien Tzu Chi Hospital, Taiwan
Section Editor: Ren-Jun Hsu Cancer Research Center, Hualien Tzuchi Hospital, Taiwan
Section Editor: Ching Ann Liu Buddhist Tzu Chi Medical Foundation
Section Editor: Michel Modo University of Pittsburgh, USA
Koji Abe Okayama University, Japan
Mitchell S. Cairo New York Medical College, USA
Fu-Chou Cheng Taichung Veterans General Hospital, Taiwan
Tzyy-Wen Chiou National Dong Hwa University, Taiwan
Der-Yang Cho China Medical University Hospital, Taiwan
Ru-Huei Fu China Medical University Hospital, Taiwan
Xiaosong Gu Nantong University, China
Horng-Jyh Harn Hualien Tzu Chi Hospital, Taiwan
Niranjan Khandelwal Postgraduate Institute of Medical Education and Research, India
Shih-Ping Liu China Medical University, Taiwan
Shinichi Matsumoto Baylor Research Institute, USA
Greg Nowak Karolinska Institute, Sweden
Dario Siniscalco Second University of Naples, Italy
Hong-Lin Su National Chung Hsing University, Taiwan
Xiao-Ming Xu Indiana University, USA
Wise Young Rutgers State University of New Jersey, USA
Founding Editors
Founding Editor: Paul R. Sanberg University of South Florida Morsani College of Medicine, USA
Co-Founding Editor: Camillo Ricordi University of Miami, USA
  • CABI: CAB Abstracts
  • CABI: Global Health
  • Clarivate Analytics: BIOSIS Previews
  • Clarivate Analytics: Current Contents - Life Sciences
  • Clarivate Analytics: Science Citation Index (SCI)
  • Clarivate Analytics: Science Citation Index Expanded
  • Directory of Open Access Journals (DOAJ)
  • ProQuest
  • PubMed Central (PMC)
  • PubMed: MEDLINE

    Before you submit your research, please make sure your paper meets the below criteria:

    1. Your paper is an original work and has not been published or currently under review with another journal.

    2. Only authors that have contributed to the work are added. Please see ICMJE's guidelines "Defining Roles of Authors and Contributors". 

    3. Your work meets all Research Ethics and Reporting Standards. 

    4. Your figures are of acceptable quality and uploaded as separate files. Line art should be 900-1200 DPI, images 300 DPI. Images should be minimally processes to uphold their original integrity. More figure information here. Please consult our guidance on gels and blots here

    5. Your references are formatted correctly and numbered as they appear in the text. Please see here for reference style.  

    6. Data and complete methods should be made available so that others may replicate your study. If applicable, please see here for more information and data repositories.  

    7. Authors must have an understanding and agreement to pay any applicable article processing charges (APCs).

    8. Only manuscripts of sufficient quality that meet the aims & scope of the journal will be reviewed.

    9. Full guidelines are below. Submissions that don't adhere to these instructions will be returned prior to peer review. 

    Once your manuscript meets all criteria above and below, you can submit it through our online submission system here.


    This Journal is a member of the Committee on Publication Ethics. This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).


    This Journal is a member of the Committee on Publication Ethics.

    This Journal recommends that authors follow the Uniform Requirements for Manuscripts Submitted to
    Biomedical Journals
    formulated by the International Committee of Medical Journal Editors (ICMJE).

    SAGE Publishing disseminates high-quality research and engaged scholarship globally, and we are committed to diversity and inclusion in publishing. We encourage submissions from a diverse range of authors from across all countries and backgrounds.

    As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

    Please include a cover letter, containing the name, full mailing address, telephone, email address and fax number (if applicable) of the author responsible for correspondence. Follow the Preparing Your Manuscript (section 6) guidelines below to prepare the manuscript, figures, and tables.

    If you have any questions about publishing with SAGE, please visit the SAGE Journal Solutions Portal

    Please read the Manuscript Submission Guidelines below before submitting your manuscript here: 



    1. Open Access
    2. Article processing charge (APC)
    3. What do we publish?
      3.1 Aims & scope
      3.2 Article types
      3.3 Writing your paper
      3.3.1 Making your article discoverable 
    4. Editorial policies
      4.1 Peer Review Policy
      4.2 Authorship
      4.3 Acknowledgements
      4.4 Funding
      4.5 Declaration of conflicting interests
      4.6 Research ethics and patient consent
      4.6.1 Use of Animal- and Human- derived tissue
      4.7 Clinical Trials
      4.8 Reporting guidelines
      4.9 Research data
    5. Publishing policies
      5.1 Publication ethics
      5.1.1 Plagiarism
      5.1.2 Previous publication
      5.2 Contributor's publishing agreement
    6. Preparing your manuscript
      6.1 Word processing formats
      6.2 Artwork, figures and other graphics
      6.3 Supplemental material
      6.4 Reference style
      6.5 English language editing services
    7. Submitting your manuscript
      7.1 How to submit your manuscript
      7.2 Title, keywords and abstracts
      7.3 Information required for completing your submission
      7.3.1 Corresponding author contact details
      7.4 ORCID
      7.5 Information required for completing your submission
      7.6 Permissions
    8. On acceptance and publication
      8.1 SAGE Production
      8.2 Continuous publication
      8.3 Promoting your article
    9. Further information


    1. Open Access

    Cell Transplantation is an open access, peer-reviewed journal. Each article accepted by peer review is
    made freely available online immediately upon publication, is published under a Creative Commons
    license and will be hosted online in perpetuity. Publication costs of the journal are covered by the
    collection of article processing charges which are paid by the funder, institution or author of each
    manuscript upon acceptance. There is no charge for submitting a paper to the journal.

    For general information on open access at SAGE please visit the Open Access page or view our Open
    Access FAQs

    Back to top

    2. Article processing charge (APC)

    e-time article processing charge (APC) is payable. This APC covers the cost of publication and ensures that your article will be freely available online in perpetuity under a Creative Commons license.

    The article processing charge (APC) is currently $2300 USD.

    The APC is payable upon acceptance after peer review and subject to VAT where applicable.

    Back to top

    3. What do we publish?

    3.1 Aims & scope

    Before submitting your manuscript to Cell Transplantation, please ensure you have read the Aims & Scope.

    3.2 Article types

    On the first page should be the abstract (a maximum of 300 words) and 4-6 keywords. All
    tables should be placed at the end of the file and numbered in the order they appear in the
    text. We strongly encourage the appropriate use of bar charts and line graphs to illustrate key
    findings. Figures should be placed in individual files (we accept TIFF, JPEG, and eps), separate
    from the main document file.
    Article types published by Cell Transplantation are given below; certain article types
    observe limits on words and in-text tables. Please see below. Word limits include tables,
    but not abstracts, key words, or references.

    • Original Research– Peer-reviewed, high-quality research investigations that represent
      new and significant contributions to science. We also encourage the submission of negative or null findings of well-conducted studies. We recognize that these can be a useful resource for the research community and can play an important role in scientific advancement and addressing the issue of publication bias.  
    • Reviews– Reviews of major areas in cellular transplantation. These may be of any length,
      may include figures (schematics) and are peer reviewed.
    • Brief Communications – Timely and brief peer-reviewed studies.
      • Maximum of 2000 words, two tables or two figures (or one table and one figure). Maximum
        page limit is 5 pages once typeset, not including the reference list.
    • Case Studies
    • Validation Studies- Validation or Replication studies can be submitted to the journal. These should be carried out to validate that a scientific finding is accurate, reliable and reproducible. These may be written in the style of a Brief Communication or a Research Paper with a brief introduction. 
    • Editorials/Letters to the Editor– Editor’s opinion or insight on a topic/ Readers'
      comments on journal articles and other matters of interest to transplant researchers. A letter to the Editor is a brief communication that either addresses the contents of a published article, or is a correspondence unrelated to a specific article. Its purpose is to make corrections, provide alternative viewpoints, or offer counter arguments. Avoid logical fallacies and ad hominem attacks. Letters to the Editor must be written in a professional tone and include references to support all claims if appropriate.A letter to the Editor unrelated to a specific article should not exceed 500 words or have more than 3 references. A letter to the Editor pertaining to a recently published article or to be published concurrently with an article within the journal should not exceed 800 words or have more than 5 references. If an abstract is included, it will automatically be made the first paragraph. Letters should not include figures or research material. Letters to the editor are not charged an APC.
    • Announcements and News – Notices of upcoming meetings, conferences,
      seminars, and other events of interest to those in the field.
    • Commentary– May be for responses to published papers, responses to other comments,
      opinion pieces on new or old important topics in the field, etc.
    • Meta-Analysis –Manuscripts in which statistical analysis was used to compare results of multiple published studies. The difference between a meta-analysis and a review article is the use of statistical analysis, thus a meta-analysis should be formatted like an original article with the following sections: Abstract, Introduction, Materials and Methods, Results, and Discussion.

    Editorials and Commentaries will not be charged an APC.

    All article types require a structured abstract except commentaries, which include a summary.

    Cell Transplantation uses the Council of Science Editors (citation-sequence) style for formatting
    citations and the reference list.

    3.3 Writing your paper

    The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.

    3.3.1 Making your article discoverable 

    When writing up your paper, think about how you can make it discoverable. The title,
    keywords and abstract are key to ensuring readers find your article through search
    engines such as Google. For information and guidance on how best to title your article,
    write your abstract and select your keywords, have a look at this page on the Gateway:
    How to Help Readers Find Your Article Online

    Back to top

    4. Editorial policies

    4.1 Peer review policy

    Following a preliminary triage to eliminate submissions unsuitable for Cell Transplantation, all
    papers are sent out for review.

    The journal’s policy is to have manuscripts reviewed by two expert reviewers. Cell
    Transplantation utilizes a single- blind peer review process in which the reviewer’s names and
    information is withheld from the author.

    Reviewers are expected to not possess any conflicts of interest with the authors and research.
    They should review the science objectively and provide recommendations for improvements
    where necessary. When aware of relevant published work not being cited, the reviewers should
    recommend inclusion of these references. If the reviewer feels that they would be unable to
    repeat the study as described, then additional methodological details should be requested. Any
    unpublished information read by a reviewer should be treated as confidential.

    All manuscripts are reviewed as rapidly as possible, while maintaining rigor. Peer review is
    managed by the Cell Transplantation Editorial Office Peer who assigns each submitted
    manuscript to appropriate reviewers and, with the input of the Editorial Board, and comments
    and recommendations of the reviewers, makes decisions on the eligibility of the article for
    publication. Neither the editors nor members of the editorial board are involved in the peer review
    process for manuscripts authored by themselves or colleagues at their own institutions. 

    4.2 Authorship

    Papers should only be submitted for consideration once consent is given by all contributing
    authors. Those submitting papers should carefully check that all those whose work contributed
    to the paper are acknowledged as contributing authors.
    The list of authors should include all those who can legitimately claim authorship. This is all
    those who:

    (i) Made a substantial contribution to the concept or design of the work; or acquisition,
    analysis or interpretation of data,
    (ii) Drafted the article or revised it critically for important intellectual content,
    (iii) Approved the version to be published,
    (iv) Each author should have participated sufficiently in the work to take public
    responsibility for appropriate portions of the content.

    Authors should meet the conditions of all of the points above. Each author should have
    participated sufficiently in the work to take public responsibility for appropriate portions of the

    When a large, multicentre group has conducted the work, the group should identify the
    individuals who accept direct responsibility for the manuscript. These individuals should fully
    meet the criteria for authorship.

    Acquisition of funding, collection of data, or general supervision of the research group alone
    does not constitute authorship, although all contributors who do not meet the criteria for
    authorship should be listed in the Acknowledgments section. Please refer to the International
    Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on

    The reported research must be novel and authentic and the authors should confirm that the
    same data has not been and is not going to be submitted to another journal (unless already
    rejected). Statements made in the introduction and discussion should be supported by
    appropriate references and sufficient experimental detail should be provided to allow for
    repetition of the study by another group. Plagiarism of the text/data will not be tolerated and
    could result in retraction of an accepted article. Any text or figures reproduced for another
    source require the permission of the original copyright holders (normally the publishers).

    Any manipulation of figures should be equally applied and described in the text including
    pseudo-coloring and must not change the meaning of the figure.

    When humans, animals or tissue derived from them have been used, then mention of the
    appropriate ethical approval must be included in the manuscript.

    4.3 Acknowledgements

    All contributors who do not meet the criteria for authorship should be listed in an
    Acknowledgements section. Examples of those who might be acknowledged include a person
    who provided purely technical help, or a department chair who provided only general support.
    Financial support and conflicts of interest for all authors must be declared. Further information
    on this can be obtained from the International Committee for Medical Journal Editors
    Please acknowledge any funding support. In addition, all authors need to disclose any conflicts
    of interest, financial or otherwise, in a separate section before the references. Conflicts of
    interest may include: 

    1. Direct ownership of equity or shares in a health care or pharmaceutical company
    relating to the manuscript, by any author or their immediate family members.
    2. Receipt of any form of income by any author or their immediate family members from
    health care or pharmaceutical companies related to the manuscript within the calendar
    year preceding original submission.
    3. Personal interest such as being an expert witness, public advocate, grantee, consultant,
    founder, owner, or employee of a health care or pharmaceutical company related to the

    4.3.1 Third party submissions

    Where an individual who is not listed as an author submits a manuscript on behalf of the author(s), a statement must be included in the Acknowledgements section of the manuscript and in the accompanying cover letter. The statements must:

    •    Disclose this type of editorial assistance – including the individual’s name, company and level of input 
    •    Identify any entities that paid for this assistance 
    •    Confirm that the listed authors have authorized the submission of their manuscript via third party and approved any statements or declarations, e.g. conflicting interests, funding, etc.

    Where appropriate, SAGE reserves the right to deny consideration to manuscripts submitted by a third party rather than by the authors themselves.

    4.3.2 Writing assistance

    Individuals who provided writing assistance, e.g. from a specialist communications company, do
    not qualify as authors and so should be included in the Acknowledgements section. Authors
    must disclose any writing assistance – including the individual’s name, company and level of
    input – and identify the entity that paid for this assistance.
    It is not necessary to disclose use of language polishing services.

    Any acknowledgements should appear first at the end of your article prior to your Declaration of
    Conflicting Interests (if applicable), any notes and your References.

    4.4 Funding

    Cell Transplantation requires all authors to acknowledge their funding in a consistent fashion
    under a separate heading. Please visit the Funding Acknowledgements page on the SAGE
    Journal Author Gateway to confirm the format of the acknowledgment text in the event of
    funding, or state that: This research received no specific grant from any funding agency in the
    public, commercial, or not-for-profit sectors.

    4.5 Declaration of conflicting interests

    It is the policy of Cell Transplantation to require a declaration of conflicting interests from all
    authors enabling a statement to be carried within the paginated pages of all published articles.

    Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of
    your manuscript, after any acknowledgements and prior to the references. If no conflict exists,
    please state that ‘The Author(s) declare(s) that there is no conflict of interest’.

    In addition, there are sections for detailing any conflicts of interest and financial support and
    that you (as corresponding/submitting author) have the permission of the other authors to
    submit the manuscript.

    For guidance on conflict of interest statements, please see the ICMJE recommendations.

    4.6 Research ethics and patient consent

    Medical research involving human subjects must be conducted according to the World Medical
    Association Declaration of Helsinki

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct,
    Reporting, Editing, and Publication of Scholarly Work in Medical Journals

    All papers reporting animal and/or human studies must state in both the Methods section and in
    the ethical statements (following the Conclusion, before the References) that the relevant Ethics
    Committee, Institutional Review Board (IRB), or Institutional Animal Care and Use Committee
    (IACUC) provided (or waived) approval. Please ensure that you have provided the full name and
    institution of the review committee, in addition to the approval number.

    • Please address the following statements. Please refer to the sample statements in this
      template (Word doc) to help you decide which statement is applicable for your work.
      Include these at the end of your manuscript directly in the document.
    • Ethical Approval
    • Statement of Human and Animal Rights
    • Statement of Informed Consent
    • For research articles, case reports, and other relevant articles, authors
      are required to state whether participants provided informed consent
      for patients information and images to be published and whether the
      consent was written or verbal or provided by a legally authorized

    Information on informed consent to report individual cases or case series should be included in the
    manuscript text. A statement is required regarding whether written informed consent for patient
    information and images to be published was provided by the patient(s) or a legally authorized
    representative. Please do not submit the patient’s actual written informed consent with your article, as
    this in itself breaches the patient’s confidentiality. The Journal requests that you confirm to us, in writing,
    that you have obtained written informed consent but the written consent itself should be held by the
    authors/investigators themselves, for example in a patient’s hospital record. The confirmatory letter may
    be uploaded with your submission as a separate file.

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants

    4.6.1 Use of Animal- and Human- derived tissue

    Please confirm within the text that the appropriate ethical and/or regulatory body approved the
    use of animal- or human-derived tissue (as well as informed consent for humans). With human
    derived data, articles are published on the understanding that appropriate measures to protect
    the privacy of the individuals were undertaken.

    4.7 Clinical trials

    Cell Transplantation conforms to the ICMJE requirement that clinical trials are registered in a
    WHO-approved public trials registry at or before the time of first patient enrolment as a
    condition of consideration for publication. The trial registry name and URL, and registration
    number must be included at the end of the abstract.

    4.8 Reporting guidelines

    The relevant EQUATOR Network reporting guidelines should be followed depending on the type
    of study. For example, all randomized controlled trials submitted for publication should include
    a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should
    be uploaded with your submission as a supplementary file. Systematic reviews and metaanalyses
    should include the completed PRISMA flow chart as a cited figure and the completed
    PRISMA checklist should be uploaded with your submission as a supplementary file. The
    EQUATOR wizard can help you identify the appropriate guideline.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.

    4.9 Research data

    The journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the SAGE Research Data policy pages.

    Subject to appropriate ethical and legal considerations, authors are encouraged to:

    • share your research data in a relevant public data repository
    • include a data availability statement linking to your data. If it is not possible to share your data, we encourage you to consider using the statement to explain why it cannot be shared.
    • cite this data in your research

    Back to top

    5. Publishing policies

    5.1 Publication ethics

    SAGE is committed to upholding the integrity of the academic record. We encourage authors to
    refer to the Committee on Publication Ethics’ International Standards for Authors and view the
    Publication Ethics page on the SAGE Author Gateway.

    5.1.1 Plagiarism

    Cell Transplantation and SAGE take issues of copyright infringement, plagiarism or other
    breaches of best practice in publication very seriously. We seek to protect the rights of our
    authors and we always investigate claims of plagiarism or misuse of published articles. Equally,
    we seek to protect the reputation of the journal against malpractice. Submitted articles may be
    checked with duplication-checking software. Where an article, for example, is found to have
    plagiarized other work or included third-party copyright material without permission or with
    insufficient acknowledgement, or where the authorship of the article is contested, we reserve
    the right to take action including, but not limited to: publishing an erratum or corrigendum
    (correction); retracting the article; taking up the matter with the head of department or dean of
    the author's institution and/or relevant academic bodies or societies; or taking appropriate legal

    5.1.2 Prior publication

    If material has been previously published, it is not generally acceptable for publication in a SAGE
    journal. However, there are certain circumstances where previously published material can be
    considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in
    doubt, contact the Editor at the address given below.

    5.2 Contributor's publishing agreement

    Before publication SAGE requires the author as the rights holder to sign a Journal Contributor’s
    Publishing Agreement. Cell Transplantation publishes manuscripts under Creative Commons
    The standard license for the journal is Creative Commons by Attribution NonCommercial
    (CC BY-NC), which allows others to re-use the work without permission as long as
    the work is properly referenced and the use is non-commercial. For more information, you are
    advised to visit SAGE's OA licenses page.

    Alternative license arrangements are available, for example, to meet particular funder
    mandates, made at the author’s request. 

    Back to top

    6. Preparing your manuscript

    6.1 Word processing formats

    Preferred formats for the text and tables of your manuscript are Word DOC, RTF, XLS. Papers
    should be typed in English, double-spaced throughout with at least 3-cm margins on paper 
    approximately 22 ´ 28 cm (8 1/2 ´ 11 in.) in size. Please consult the most recent issue of the
    journal for style and format. Number all pages consecutively, beginning with the title page. Use
    metric units of measure; other units may be given in parentheses. Typically, only three levels of
    headings are recognized. The paper should be organized as follows.

    Title Page: The title should be brief and specific. The title page should contain, in the following
    order: title, name(s) and affiliation(s) of author(s) including city, state, postal code, and country,
    and a suggested running head of not more than 50 characters and spaces. Also indicate which
    author will be the corresponding author (i.e., to whom correspondence should be addressed,
    with complete mailing address, telephone and fax numbers, and e-mail necessary for sending
    proofs). In general, no more than two shared first and/or senior authorships can be considered
    and they must be appropriately justified in the letter to the editor at the time of submission. The
    rule can be reassessed on a case-by-case basis for manuscripts arising from multicenter
    collaborations, but please note that the production office will not liaise with more than two
    corresponding authors. In the case of two corresponding authors, the proof will only be sent to
    the first mentioned corresponding author.

    Abstract: An abstract of 300 words or less should begin on page 2. It should contain a concise
    summary of the results, conclusions, and other significant points in the review.

    Key words: For the purpose of subject indexing, provide four to six keywords immediately
    following the abstract.

    Text: Every effort should be made to avoid jargon, to spell out all nonstandard abbreviations the
    first time they are used, and to present the contents of the study as clearly and concisely as
    possible. In the Materials and Methods section, authors are required to supply sufficient detail
    for replication of the study, including the name of the company from which the materials
    (reagents and equipment) were supplied and the location of company headquarters (city, state
    if in the U.S., and country). References to previously described methods must be properly cited
    and also described in moderate detail. References should be given for all discussions and
    conclusions of previous studies. Trade names may appear in parentheses and should be
    capitalized. Critical discussions of the literature are preferred more than historically oriented

    6.2 Artwork, figures and other graphics

    Tables: All tables must be created in Microsoft Word. Tables should be numbered and cited
    sequentially in the text. Prepare each table as a separate page at the end of the manuscript text,
    after the references. Avoid very wide or long tables that would not fit a printed page. Each table
    should have a title, and each column in the table should have a brief heading. Define all
    abbreviations in the table footnote at the bottom of the table.

    Figures: Figures should be numbered and cited sequentially in the text. Each figure should be
    provided as a separate file (see Final Accepted Manuscript). Include all parts of a figure (e.g., A,
    B, etc.) as one file. Do not use light lettering and shading that will not reproduce well. Figure
    dimensions and scaling should be suitable for reduction (if necessary) to fit column or page size.
    Care must be taken that letters and other symbols do not become so small that they are illegible
    when the figure is reduced. Complex formulas should be prepared as illustrations. (Do not
    embed figures within the manuscript text.) The author is required to bear the costs for the
    publication of color figures (costs and color authorization form will be provided at proof stage).
    Authors may submit a color photograph for consideration as a cover photo for the issue in which
    their article appears. Please consult our guide on preparing blots and gels if they will be included in figures. 

    Figure Legends: Each figure legend must have a short title that concisely describes the content
    of each figure. List all figure legends sequentially on one or more pages at the end of the
    manuscript text, after the references, and identify all symbols used in the figures. The figure
    legend should be as clear as possible and should fully describe the contents of the figure. (Do
    not include the figure legend as part of the figure). If the figure is from a previously published
    article, indicate that permission has been obtained from the original publisher.

    Figure Files: Each figure should be provided as a separate, high-resolution file. Simple black and
    white figures (e.g., line graphs, bar graphs, etc.) should be 1200 dpi. Halftone and color figures
    (or combo figures) should be 600 dpi. Final figure files should be submitted as tiff, jpg, or eps
    format. Do not include the figure number as part of the figure file (e.g., do not label Figure 1,
    etc., as part of the figure). Do not provide color in a figure file unless the figure will be printed in
    color (note there is a cost for printing figures in color).

    6.3 Supplemental material

    This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images
    etc) alongside the full-text of the article. These will be subjected to peer-review alongside the
    article. For more information please refer to our guidelines on submitting supplementary files,
    which can be found within our Manuscript Submission Guidelines page

    6.4 Reference style

    Literature cited should be prepared according to the Council of Science Editors format (citationsequence)
    style. This format is conveniently in Endnote and the output style is available at the
    following site:
    Some examples are provided below. References in the text should be cited by superscript number separated by a comma and listed in numerical order as they appear in the text (double
    spaced) on a separate page at the end of the manuscript. Journal citations in the reference list
    should contain the following: (a) reference number NOT in superscript; (b) surnames and initials
    of up to the first 11 authors (surnames precede initials); (c) title of article; (d) journal title abbreviated as listed
    in; (e) year; volume, inclusive pages. See the examples shown and refer to Council of
    Science Editors format for more examples.

    Journal Article: Wang Y, Nathanson L, McNiece IK. Differential hematopoietic supportive
    potential and gene expression of stroma cell lines from midgestation mouse placenta and adult
    bone marrow. Cell Transplant. 2011;20:707–26.

    Book Article/Chapter: Taylor MJ, Baicu, S. Hypothermic perfusion of pancreas: Emphasis on
    preservation prior to islet isolation. In: Uygun K, Lee CY, editors. Organ preservation and
    reengineering. Boston (MA): Artech House Publisher; 2011. p. 85-104.

    Book: Wang-Fischer Y. Manual of stroke models in rats, 1st ed. Boca Raton (FL): CRC Press; 2009.

    Internet Source: Stem Cell Research Oversight Committee. University of Wisconsin-Madison
    policy for multisite research studies using human pluripotent stem cells [Internet]. Madison
    (WI): University of Wisconsin-Madison; 2009 [cited 2013 Sep 12]. Available from

    An example of an in-text citation is shown below.

    Traumatic life events and posttraumatic stress disorder (PTSD) are endemic among American

    To cite multiple sources, all numbers associated with the reference being cited should be
    superscript, separated by a comma, with no spaces between them.

    Statistics: If statistical analysis was performed, define the tests used in the methods and ensure
    that it is clear what comparisons are made. Please ensure that appropriate testing was
    performed when multiple comparisons (i.e., one group compared to more than one other
    group) were made.

    6.5 English language editing services

    Manuscripts should be grammatically correct and completely comprehendible upon submission
    before they will be forwarded for peer review.

    Authors seeking assistance with English language editing, translation, or figure and manuscript
    formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit
    SAGE Language Services on our Journal Author Gateway for further information. 

    Back to top

    7. Submitting your manuscript

    7.1 How to submit your manuscript

    Cell Transplantation is hosted on SAGE Track, a web based online submission and peer review
    system powered by ScholarOne™ Manuscripts. Visit to login and submit your article online.

    IMPORTANT: Please check whether you already have an account in the system before trying to
    create a new one. If you have reviewed or authored for the journal in the past year it is likely
    that you will have had an account created. For further guidance on submitting your manuscript
    online please visit ScholarOne Online Help.

    7.2 Title, keywords and abstracts

    Please supply a title, short title, an abstract and keywords to accompany your article. The title,
    keywords and abstract are key to ensuring readers find your article online through online search
    engines such as Google. Please refer to the information and guidance on how best to title your
    article, write your abstract and select your keywords by visiting the SAGE Journal Author
    Gateway for guidelines on How to Help Readers Find Your Article Online

    7.3 Information required for completing your submission

    Provide full contact details for the corresponding author including email, mailing address and
    telephone numbers. Academic affiliations are required for all co-authors. These details should
    be presented separately to the main text of the article to facilitate anonymous peer review.
    You will be asked to provide contact details and academic affiliations for all co-authors via the
    submission system and identify who is to be the corresponding author. These details must
    match what appears on your manuscript. At this stage please ensure you have included all the
    required statements and declarations and uploaded any additional supplementary files
    (including reporting guidelines where relevant).

    7.3.1 Corresponding author contact details

    Provide full contact details for the corresponding author including email, mailing address and
    telephone numbers. Academic affiliations are required for all co-authors. These details should
    be presented separately to the main text of the article to facilitate anonymous peer review.

    7.4 ORCID

    As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE
    is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a
    unique and persistent digital identifier that distinguishes researchers from every other researcher,
    even those who share the same name, and, through integration in key research workflows such
    as manuscript and grant submission, supports automated linkages between researchers and their
    professional activities, ensuring that their work is recognized.

    The collection of ORCID IDs from corresponding authors is now part of the submission process of
    this journal. If you already have an ORCID iD you will be asked to associate that to your submission
    during the online submission process. We also strongly encourage all co-authors to link their ORCID
    ID to their accounts in our online peer review platforms. It takes seconds to do: click the link when
    prompted, sign into your ORCID account and our systems are automatically updated. Your ORCID
    iD will become part of your accepted publication’s metadata, making your work attributable to you
    and only you. Your ORCID iD is published with your article so that fellow researchers reading your
    work can link to your ORCID profile and from there link to your other publications.

    If you do not already have an ORCID ID please follow this link to create one or visit our ORCID homepage
    to learn more.

          7.5 Information required for completing your submission

           You will be asked to provide contact details and academic affiliations for all co-authors via the
           submission system and identify who is to be the corresponding author. These details must match what
           appears on your manuscript. The affiliation listed on the manuscript should be the institution where the
           research was conducted. If an author has moved to a new institution since completing the research, the
           new affiliation can be included in a manuscript note at the end of the paper. At this stage please ensure
           you have included all the required statements and declarations and uploaded any additional
           supplementary files (including reporting guidelines where relevant).

    7.6 Permissions

    Authors are responsible for obtaining permission from copyright holders for reproducing any
    illustrations, tables, figures or lengthy quotations previously published elsewhere. For further
    information including guidance on fair dealing for criticism and review, please visit our
    Frequently Asked Questions on the SAGE Journal Author Gateway.

    Back to top

    8. On acceptance and publication

    If your paper is accepted for publication after peer review, you will first be asked to complete the
    contributor’s publishing agreement. All material accepted for publication is subject to copyediting.
    Authors will receive page proofs of articles before publication, along with an APC authorization form
    (with the final cost based on the number of printed pages) and Color Figure authorization form (if there
    are potential color figures), which will need to be completed and returned before the article can be
    processed for publication. Note that if the figures were originally in color but you decide not to print in
    color at proof stage the text/legends may need to be modified to reflect this change. Please note that if
    the lack of color makes the figure difficult to interpret then revised figures (or agreement to pay for
    color) may be required.

    8.1 SAGE Production

    Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production
    process. Proofs will made available to the corresponding author via our editing portal SAGE Edit, or by
    email to the corresponding author and should be returned promptly.  Authors are reminded to check their
    proofs carefully to confirm that all author information, including names, affiliations, sequence and contact
    details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note
    that if there are any changes to the author list at this stage all authors will be required to complete and sign
    a form authorizing the change.

    8.2 Online publication

    One of the many benefits of publishing your research in an open access journal is the speed to
    publication. With no page count constraints, your article will be published online in a fully
    citable form with a DOI number as soon as it has completed the production process. At this time
    it will be completely free to view and download for all. 

    8.3 Promoting your article

    Publication is not the end of the process! You can help disseminate your paper and ensure it is
    as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help
    you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice.

    Back to top

    9. Further information

    Any correspondence, queries or additional requests for information on the Manuscript Submission process should be sent to the Managing Editor, Samantha Portis at Tel: 813 974 4691.

    Back to top